Dennis Roop
Concepts (837)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermis | 84 | 2024 | 156 | 8.390 |
Why?
| | Keratins | 113 | 2016 | 171 | 6.560 |
Why?
| | Keratinocytes | 56 | 2024 | 249 | 4.120 |
Why?
| | Skin Neoplasms | 57 | 2024 | 865 | 3.810 |
Why?
| | Membrane Proteins | 39 | 2022 | 1171 | 3.500 |
Why?
| | Skin | 53 | 2024 | 759 | 3.120 |
Why?
| | Trans-Activators | 26 | 2013 | 398 | 2.770 |
Why?
| | Phosphoproteins | 17 | 2013 | 337 | 2.010 |
Why?
| | Papilloma | 31 | 2011 | 49 | 2.000 |
Why?
| | Cell Transformation, Neoplastic | 25 | 2016 | 340 | 1.990 |
Why?
| | Cell Differentiation | 74 | 2024 | 2054 | 1.940 |
Why?
| | Hyperkeratosis, Epidermolytic | 17 | 2008 | 21 | 1.910 |
Why?
| | Mice, Transgenic | 66 | 2017 | 2197 | 1.850 |
Why?
| | NF-E2-Related Factor 2 | 7 | 2022 | 103 | 1.800 |
Why?
| | Stem Cells | 19 | 2017 | 630 | 1.780 |
Why?
| | Mice | 189 | 2024 | 18491 | 1.660 |
Why?
| | Genes, ras | 25 | 2012 | 96 | 1.480 |
Why?
| | Animals | 232 | 2024 | 38410 | 1.400 |
Why?
| | Hair Follicle | 14 | 2020 | 49 | 1.340 |
Why?
| | Vitiligo | 8 | 2024 | 42 | 1.190 |
Why?
| | Genetic Therapy | 12 | 2014 | 317 | 1.190 |
Why?
| | Mutation | 37 | 2024 | 4130 | 1.070 |
Why?
| | Melanocytes | 8 | 2024 | 65 | 1.070 |
Why?
| | Point Mutation | 13 | 2009 | 245 | 1.050 |
Why?
| | Skin Diseases | 8 | 2014 | 152 | 1.000 |
Why?
| | Carcinoma, Squamous Cell | 20 | 2016 | 648 | 0.980 |
Why?
| | Induced Pluripotent Stem Cells | 6 | 2024 | 277 | 0.980 |
Why?
| | Transforming Growth Factor alpha | 10 | 2000 | 55 | 0.890 |
Why?
| | Cell Division | 20 | 2016 | 758 | 0.890 |
Why?
| | Collagen Type VII | 2 | 2024 | 27 | 0.890 |
Why?
| | Ichthyosis | 7 | 2016 | 15 | 0.870 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2024 | 42 | 0.870 |
Why?
| | Mice, Knockout | 35 | 2018 | 3153 | 0.860 |
Why?
| | Disease Models, Animal | 31 | 2020 | 4604 | 0.850 |
Why?
| | Gene Expression Regulation | 31 | 2016 | 2625 | 0.830 |
Why?
| | Phenotype | 28 | 2021 | 3216 | 0.820 |
Why?
| | Ectodermal Dysplasia | 5 | 2009 | 20 | 0.820 |
Why?
| | Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 9 | 0.800 |
Why?
| | Melanoma | 10 | 2020 | 774 | 0.800 |
Why?
| | Morphogenesis | 7 | 2010 | 171 | 0.800 |
Why?
| | Base Sequence | 49 | 2016 | 2175 | 0.790 |
Why?
| | Gene Expression Regulation, Developmental | 14 | 2015 | 915 | 0.770 |
Why?
| | Ultraviolet Rays | 9 | 2024 | 385 | 0.770 |
Why?
| | DNA-Binding Proteins | 15 | 2015 | 1488 | 0.770 |
Why?
| | Genes, fos | 10 | 2000 | 36 | 0.760 |
Why?
| | Neoplasms, Experimental | 4 | 2019 | 167 | 0.750 |
Why?
| | Genes, p53 | 10 | 2012 | 67 | 0.740 |
Why?
| | Transgenes | 13 | 2016 | 190 | 0.740 |
Why?
| | Tetradecanoylphorbol Acetate | 21 | 2010 | 149 | 0.730 |
Why?
| | Tumor Suppressor Proteins | 8 | 2009 | 323 | 0.710 |
Why?
| | Proto-Oncogene Proteins c-myc | 6 | 2010 | 169 | 0.700 |
Why?
| | Tumor Suppressor Protein p53 | 6 | 2011 | 536 | 0.700 |
Why?
| | Cells, Cultured | 39 | 2024 | 4169 | 0.690 |
Why?
| | Skin Pigmentation | 4 | 2024 | 48 | 0.690 |
Why?
| | Gene Expression Regulation, Neoplastic | 18 | 2015 | 1457 | 0.690 |
Why?
| | Intermediate Filament Proteins | 22 | 2012 | 57 | 0.680 |
Why?
| | Jews | 1 | 2021 | 20 | 0.680 |
Why?
| | Skin Physiological Phenomena | 7 | 2008 | 24 | 0.670 |
Why?
| | Neoplastic Stem Cells | 7 | 2016 | 409 | 0.630 |
Why?
| | Cell Lineage | 5 | 2010 | 381 | 0.610 |
Why?
| | Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.600 |
Why?
| | Cytoskeletal Proteins | 9 | 2012 | 158 | 0.600 |
Why?
| | Intravital Microscopy | 1 | 2019 | 24 | 0.590 |
Why?
| | Molecular Sequence Data | 34 | 2012 | 2886 | 0.590 |
Why?
| | Transcription Factors | 16 | 2015 | 1747 | 0.580 |
Why?
| | Genes, myc | 4 | 2011 | 51 | 0.570 |
Why?
| | Pluripotent Stem Cells | 2 | 2010 | 81 | 0.540 |
Why?
| | Hair | 6 | 2012 | 84 | 0.540 |
Why?
| | Signal Transduction | 22 | 2020 | 5272 | 0.530 |
Why?
| | Hedgehog Proteins | 7 | 2017 | 201 | 0.530 |
Why?
| | Genes | 15 | 2008 | 230 | 0.520 |
Why?
| | Immunity, Cellular | 1 | 2019 | 280 | 0.520 |
Why?
| | Skin Diseases, Genetic | 6 | 2020 | 13 | 0.520 |
Why?
| | Mice, Mutant Strains | 14 | 2016 | 303 | 0.500 |
Why?
| | Keratin-6 | 5 | 2016 | 6 | 0.500 |
Why?
| | Promoter Regions, Genetic | 17 | 2016 | 1253 | 0.480 |
Why?
| | Multipotent Stem Cells | 3 | 2010 | 21 | 0.470 |
Why?
| | Amino Acid Sequence | 30 | 2012 | 2134 | 0.470 |
Why?
| | Protein Isoforms | 8 | 2008 | 398 | 0.470 |
Why?
| | Head and Neck Neoplasms | 5 | 2016 | 569 | 0.460 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2016 | 117 | 0.460 |
Why?
| | Ultraviolet Therapy | 4 | 2024 | 17 | 0.450 |
Why?
| | Humans | 132 | 2024 | 147293 | 0.450 |
Why?
| | Keratoderma, Palmoplantar | 3 | 2014 | 6 | 0.450 |
Why?
| | Cell Proliferation | 14 | 2024 | 2529 | 0.450 |
Why?
| | Transforming Growth Factor beta | 8 | 2009 | 475 | 0.440 |
Why?
| | Pachyonychia Congenita | 3 | 2014 | 4 | 0.440 |
Why?
| | Viral Proteins | 4 | 2002 | 353 | 0.430 |
Why?
| | Genetic Vectors | 7 | 2013 | 335 | 0.430 |
Why?
| | Tretinoin | 11 | 2014 | 125 | 0.420 |
Why?
| | Gene Deletion | 8 | 2012 | 392 | 0.420 |
Why?
| | Keratosis | 7 | 2000 | 16 | 0.420 |
Why?
| | Epithelium | 14 | 2004 | 311 | 0.420 |
Why?
| | DNA | 24 | 2018 | 1444 | 0.410 |
Why?
| | Cell Culture Techniques | 3 | 2014 | 375 | 0.410 |
Why?
| | Cadherins | 3 | 2016 | 204 | 0.410 |
Why?
| | Animals, Newborn | 23 | 2007 | 914 | 0.400 |
Why?
| | Cell Cycle | 3 | 2012 | 600 | 0.400 |
Why?
| | Mice, Inbred ICR | 10 | 2011 | 113 | 0.400 |
Why?
| | Genes, Dominant | 6 | 2016 | 100 | 0.400 |
Why?
| | Amniotic Fluid | 2 | 2012 | 79 | 0.390 |
Why?
| | Mosaicism | 5 | 2014 | 73 | 0.380 |
Why?
| | Up-Regulation | 8 | 2020 | 848 | 0.380 |
Why?
| | Nails, Malformed | 2 | 2005 | 7 | 0.380 |
Why?
| | Abnormalities, Multiple | 3 | 2014 | 199 | 0.370 |
Why?
| | Eyelids | 2 | 2009 | 41 | 0.370 |
Why?
| | Keratin-10 | 8 | 2016 | 8 | 0.360 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 17 | 2010 | 23 | 0.360 |
Why?
| | Proteomics | 2 | 2016 | 1203 | 0.360 |
Why?
| | Transcription, Genetic | 23 | 2017 | 1456 | 0.360 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 33 | 0.360 |
Why?
| | Melanoma, Experimental | 3 | 1998 | 109 | 0.360 |
Why?
| | Wnt Signaling Pathway | 2 | 2024 | 212 | 0.360 |
Why?
| | DNA Primers | 13 | 2010 | 505 | 0.360 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2012 | 430 | 0.350 |
Why?
| | Carcinogens | 12 | 2010 | 123 | 0.350 |
Why?
| | Cleft Lip | 2 | 2009 | 73 | 0.350 |
Why?
| | Mutation, Missense | 3 | 2016 | 337 | 0.350 |
Why?
| | Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.350 |
Why?
| | Apoptosis | 9 | 2012 | 2454 | 0.340 |
Why?
| | Cleft Palate | 2 | 2009 | 91 | 0.340 |
Why?
| | Wound Healing | 6 | 2010 | 361 | 0.340 |
Why?
| | Gene Transfer Techniques | 4 | 2002 | 189 | 0.340 |
Why?
| | Calcium | 12 | 2010 | 1197 | 0.330 |
Why?
| | Hyperplasia | 12 | 2002 | 177 | 0.320 |
Why?
| | Proteins | 3 | 2016 | 1024 | 0.320 |
Why?
| | Centrosome | 4 | 2012 | 72 | 0.320 |
Why?
| | Pedigree | 11 | 2000 | 522 | 0.320 |
Why?
| | Integrases | 5 | 2004 | 122 | 0.310 |
Why?
| | RNA, Messenger | 35 | 2016 | 2812 | 0.310 |
Why?
| | Alleles | 7 | 2016 | 909 | 0.310 |
Why?
| | Gene Targeting | 5 | 2008 | 81 | 0.300 |
Why?
| | Stem Cell Niche | 1 | 2010 | 58 | 0.300 |
Why?
| | Epidermolysis Bullosa Simplex | 4 | 2004 | 14 | 0.300 |
Why?
| | Transcription Factor AP-2 | 2 | 2008 | 82 | 0.290 |
Why?
| | Mice, Nude | 12 | 2016 | 680 | 0.290 |
Why?
| | Genes, Recessive | 2 | 2021 | 79 | 0.290 |
Why?
| | Immunotherapy | 3 | 2020 | 672 | 0.280 |
Why?
| | Polymerase Chain Reaction | 13 | 2002 | 1046 | 0.270 |
Why?
| | Female | 74 | 2024 | 80076 | 0.270 |
Why?
| | Mice, Inbred Strains | 13 | 2010 | 397 | 0.270 |
Why?
| | Keratins, Type II | 1 | 2007 | 2 | 0.260 |
Why?
| | Adenoviridae | 3 | 1998 | 199 | 0.260 |
Why?
| | Fluorescent Antibody Technique | 19 | 2004 | 365 | 0.260 |
Why?
| | Aurora Kinases | 3 | 2012 | 28 | 0.250 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2007 | 19 | 0.250 |
Why?
| | Aurora Kinase A | 3 | 2012 | 61 | 0.250 |
Why?
| | Lipid Metabolism | 5 | 2018 | 538 | 0.250 |
Why?
| | Keratin-14 | 6 | 2012 | 15 | 0.250 |
Why?
| | Disease Progression | 6 | 2019 | 2890 | 0.250 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 79 | 0.250 |
Why?
| | Mice, Inbred BALB C | 17 | 2020 | 1266 | 0.240 |
Why?
| | Mifepristone | 9 | 2009 | 54 | 0.240 |
Why?
| | Amino Acid Substitution | 4 | 2000 | 303 | 0.240 |
Why?
| | Skin Transplantation | 6 | 2024 | 85 | 0.240 |
Why?
| | Proto-Oncogenes | 1 | 2006 | 28 | 0.240 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 6 | 0.240 |
Why?
| | Models, Biological | 8 | 2016 | 1772 | 0.230 |
Why?
| | Genes, Reporter | 4 | 2009 | 278 | 0.230 |
Why?
| | Cell Line | 14 | 2018 | 2832 | 0.230 |
Why?
| | Homeostasis | 3 | 2020 | 651 | 0.230 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 18 | 0.230 |
Why?
| | Oncogene Protein p21(ras) | 4 | 2004 | 15 | 0.220 |
Why?
| | Genomic Instability | 4 | 2011 | 68 | 0.220 |
Why?
| | Gene Expression | 12 | 2015 | 1481 | 0.220 |
Why?
| | Male | 50 | 2024 | 73950 | 0.220 |
Why?
| | Intermediate Filaments | 6 | 2015 | 25 | 0.220 |
Why?
| | Mouth Neoplasms | 2 | 2004 | 93 | 0.220 |
Why?
| | Skin Diseases, Vesiculobullous | 2 | 1999 | 17 | 0.220 |
Why?
| | Keratin-1 | 2 | 2016 | 2 | 0.220 |
Why?
| | Mice, Inbred C57BL | 19 | 2015 | 6041 | 0.210 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 256 | 0.210 |
Why?
| | Phosphodiesterase 4 Inhibitors | 1 | 2024 | 12 | 0.210 |
Why?
| | Prenatal Diagnosis | 2 | 1998 | 196 | 0.210 |
Why?
| | Protein Precursors | 9 | 2006 | 136 | 0.210 |
Why?
| | ras Proteins | 4 | 2013 | 153 | 0.210 |
Why?
| | beta Catenin | 3 | 2020 | 254 | 0.200 |
Why?
| | Lipids | 4 | 2018 | 723 | 0.200 |
Why?
| | Retinoids | 2 | 1997 | 36 | 0.200 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 79 | 0.200 |
Why?
| | Sequence Analysis, DNA | 6 | 2016 | 780 | 0.200 |
Why?
| | Heterozygote | 4 | 2010 | 317 | 0.200 |
Why?
| | Cocarcinogenesis | 4 | 2000 | 13 | 0.200 |
Why?
| | Proto-Oncogene Proteins | 5 | 2013 | 627 | 0.190 |
Why?
| | Lac Operon | 2 | 2000 | 44 | 0.190 |
Why?
| | Transfection | 10 | 2017 | 930 | 0.190 |
Why?
| | Transduction, Genetic | 4 | 2009 | 133 | 0.190 |
Why?
| | Antioxidants | 2 | 2020 | 550 | 0.190 |
Why?
| | Tongue | 2 | 2001 | 77 | 0.190 |
Why?
| | Oncogenes | 5 | 1994 | 118 | 0.190 |
Why?
| | Cilia | 2 | 2017 | 173 | 0.190 |
Why?
| | Wnt Proteins | 3 | 2010 | 133 | 0.180 |
Why?
| | Cytoskeleton | 8 | 1994 | 193 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 980 | 0.180 |
Why?
| | Epithelial Cells | 14 | 2006 | 1141 | 0.180 |
Why?
| | Alopecia | 4 | 2005 | 37 | 0.180 |
Why?
| | Cell Membrane | 7 | 2015 | 711 | 0.180 |
Why?
| | Hindlimb | 2 | 1999 | 132 | 0.180 |
Why?
| | Micromanipulation | 1 | 2002 | 14 | 0.180 |
Why?
| | Human Growth Hormone | 1 | 2002 | 47 | 0.180 |
Why?
| | Chromosome Mapping | 5 | 2016 | 512 | 0.170 |
Why?
| | Chile | 1 | 2021 | 27 | 0.170 |
Why?
| | Colombia | 1 | 2021 | 42 | 0.170 |
Why?
| | Hair Diseases | 1 | 2001 | 10 | 0.170 |
Why?
| | Nail Diseases | 1 | 2001 | 9 | 0.170 |
Why?
| | Microscopy, Electron | 10 | 2002 | 417 | 0.170 |
Why?
| | Permeability | 3 | 2016 | 170 | 0.170 |
Why?
| | Blister | 1 | 2001 | 39 | 0.170 |
Why?
| | I-kappa B Kinase | 4 | 2009 | 52 | 0.170 |
Why?
| | Molecular Imprinting | 1 | 2020 | 5 | 0.160 |
Why?
| | Neoplasm Transplantation | 6 | 2016 | 246 | 0.160 |
Why?
| | Mexico | 1 | 2021 | 233 | 0.160 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 322 | 0.160 |
Why?
| | Carcinoma | 5 | 1995 | 231 | 0.160 |
Why?
| | RNA | 6 | 2018 | 916 | 0.160 |
Why?
| | Ceramides | 3 | 2016 | 117 | 0.160 |
Why?
| | Cloning, Molecular | 9 | 2002 | 539 | 0.160 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2008 | 269 | 0.160 |
Why?
| | Regenerative Medicine | 2 | 2019 | 49 | 0.160 |
Why?
| | Blotting, Western | 8 | 2007 | 1186 | 0.160 |
Why?
| | Adult Stem Cells | 1 | 2020 | 40 | 0.160 |
Why?
| | Laser Capture Microdissection | 2 | 2017 | 29 | 0.160 |
Why?
| | Cell Membrane Permeability | 1 | 2020 | 89 | 0.150 |
Why?
| | Molecular Weight | 15 | 1990 | 313 | 0.150 |
Why?
| | Papillomaviridae | 3 | 2016 | 116 | 0.150 |
Why?
| | Genetic Linkage | 4 | 1999 | 273 | 0.150 |
Why?
| | Fibroblasts | 6 | 2024 | 1039 | 0.150 |
Why?
| | Bimatoprost | 1 | 2019 | 3 | 0.150 |
Why?
| | Immunologic Surveillance | 1 | 2019 | 25 | 0.150 |
Why?
| | Precancerous Conditions | 4 | 2004 | 166 | 0.150 |
Why?
| | Guided Tissue Regeneration | 1 | 2019 | 13 | 0.150 |
Why?
| | Crosses, Genetic | 4 | 2010 | 123 | 0.150 |
Why?
| | Antineoplastic Agents | 5 | 2016 | 2231 | 0.150 |
Why?
| | Arginine | 2 | 2007 | 265 | 0.150 |
Why?
| | Deafness | 1 | 2000 | 79 | 0.150 |
Why?
| | Alopecia Areata | 1 | 2019 | 13 | 0.150 |
Why?
| | Skin Aging | 2 | 1997 | 22 | 0.150 |
Why?
| | Zebrafish Proteins | 1 | 2002 | 316 | 0.150 |
Why?
| | Threonine | 1 | 1999 | 44 | 0.150 |
Why?
| | Thymidine Kinase | 2 | 1998 | 16 | 0.140 |
Why?
| | Asparagine | 1 | 1999 | 35 | 0.140 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2017 | 25 | 0.140 |
Why?
| | Janus Kinase Inhibitors | 1 | 2019 | 28 | 0.140 |
Why?
| | Tumor Cells, Cultured | 7 | 2016 | 891 | 0.140 |
Why?
| | Ovalbumin | 7 | 1981 | 194 | 0.140 |
Why?
| | Caspase 14 | 1 | 2018 | 1 | 0.140 |
Why?
| | Simplexvirus | 2 | 1998 | 82 | 0.140 |
Why?
| | Microscopy, Immunoelectron | 4 | 2016 | 43 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1999 | 54 | 0.140 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 939 | 0.140 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 10 | 0.130 |
Why?
| | Transplantation, Heterologous | 3 | 2011 | 170 | 0.130 |
Why?
| | Caspase 3 | 2 | 2010 | 242 | 0.130 |
Why?
| | Autoimmunity | 1 | 2024 | 935 | 0.130 |
Why?
| | Potoroidae | 2 | 2007 | 3 | 0.130 |
Why?
| | Oncogene Proteins, Viral | 2 | 1994 | 20 | 0.130 |
Why?
| | Gene Silencing | 2 | 2016 | 203 | 0.130 |
Why?
| | Mammary Glands, Animal | 2 | 2006 | 128 | 0.130 |
Why?
| | Desmosomes | 2 | 2016 | 22 | 0.130 |
Why?
| | Receptors, Retinoic Acid | 1 | 1997 | 44 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 241 | 0.130 |
Why?
| | Protein Multimerization | 1 | 2018 | 205 | 0.120 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1997 | 55 | 0.120 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 322 | 0.120 |
Why?
| | Neovascularization, Pathologic | 1 | 1998 | 287 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 4 | 1999 | 377 | 0.120 |
Why?
| | Syndrome | 3 | 2009 | 385 | 0.120 |
Why?
| | Nucleic Acid Hybridization | 13 | 1991 | 188 | 0.120 |
Why?
| | Glucosylceramides | 1 | 2016 | 7 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 25 | 0.120 |
Why?
| | Kallikreins | 1 | 2016 | 26 | 0.120 |
Why?
| | Exons | 2 | 2016 | 365 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 669 | 0.120 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2014 | 44 | 0.120 |
Why?
| | Gene Amplification | 2 | 2011 | 118 | 0.120 |
Why?
| | Aldehyde Dehydrogenase | 2 | 2016 | 99 | 0.120 |
Why?
| | SOXB1 Transcription Factors | 1 | 2016 | 67 | 0.120 |
Why?
| | Side-Population Cells | 2 | 2013 | 8 | 0.120 |
Why?
| | Microscopy, Fluorescence | 5 | 2007 | 409 | 0.120 |
Why?
| | Cell Movement | 5 | 2019 | 966 | 0.120 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 219 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2013 | 222 | 0.110 |
Why?
| | Genes, Regulator | 2 | 1993 | 35 | 0.110 |
Why?
| | Bromodeoxyuridine | 3 | 2001 | 77 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 145 | 0.110 |
Why?
| | Receptors, Progesterone | 3 | 2002 | 244 | 0.110 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 415 | 0.110 |
Why?
| | Cetuximab | 1 | 2015 | 111 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 3 | 2015 | 435 | 0.110 |
Why?
| | Hand Deformities, Congenital | 1 | 2014 | 10 | 0.110 |
Why?
| | Chloracne | 1 | 2014 | 1 | 0.100 |
Why?
| | Trachea | 4 | 1993 | 258 | 0.100 |
Why?
| | Keratin-2 | 3 | 2000 | 3 | 0.100 |
Why?
| | Cricetinae | 9 | 1994 | 305 | 0.100 |
Why?
| | RNA, Neoplasm | 6 | 1995 | 83 | 0.100 |
Why?
| | Dermis | 2 | 2010 | 33 | 0.100 |
Why?
| | Genes, Tumor Suppressor | 2 | 2004 | 86 | 0.100 |
Why?
| | Cellular Reprogramming | 1 | 2014 | 98 | 0.100 |
Why?
| | Transcriptional Activation | 4 | 2007 | 372 | 0.100 |
Why?
| | Hormones | 2 | 1994 | 136 | 0.100 |
Why?
| | Recombination, Genetic | 2 | 2008 | 205 | 0.100 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 75 | 0.100 |
Why?
| | Embryonic and Fetal Development | 3 | 2002 | 93 | 0.100 |
Why?
| | Genetic Engineering | 2 | 2007 | 89 | 0.100 |
Why?
| | Smad4 Protein | 1 | 2013 | 34 | 0.100 |
Why?
| | DNA Mutational Analysis | 3 | 2018 | 414 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2006 | 745 | 0.100 |
Why?
| | Embryoid Bodies | 1 | 2013 | 8 | 0.100 |
Why?
| | Vagina | 3 | 1994 | 206 | 0.090 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2012 | 22 | 0.090 |
Why?
| | DNA Restriction Enzymes | 7 | 1998 | 53 | 0.090 |
Why?
| | Keratins, Hair-Specific | 1 | 2012 | 1 | 0.090 |
Why?
| | Models, Animal | 4 | 2013 | 394 | 0.090 |
Why?
| | RNA Splice Sites | 1 | 2012 | 51 | 0.090 |
Why?
| | Polymorphism, Restriction Fragment Length | 3 | 2004 | 60 | 0.090 |
Why?
| | Polyploidy | 1 | 2012 | 14 | 0.090 |
Why?
| | Macromolecular Substances | 7 | 1992 | 216 | 0.090 |
Why?
| | Cell Separation | 2 | 2007 | 306 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2003 | 731 | 0.090 |
Why?
| | Quinone Reductases | 2 | 2002 | 14 | 0.090 |
Why?
| | Dermatology | 1 | 2014 | 132 | 0.090 |
Why?
| | Immunohistochemistry | 14 | 2007 | 1730 | 0.090 |
Why?
| | Binding Sites | 4 | 2006 | 1319 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 643 | 0.090 |
Why?
| | Embryo, Mammalian | 3 | 2010 | 234 | 0.090 |
Why?
| | Fetal Diseases | 1 | 1994 | 194 | 0.090 |
Why?
| | MicroRNAs | 2 | 2015 | 694 | 0.090 |
Why?
| | Cancer Vaccines | 3 | 1998 | 164 | 0.090 |
Why?
| | Cerebellar Ataxia | 1 | 2011 | 13 | 0.080 |
Why?
| | Immunocompetence | 1 | 2011 | 46 | 0.080 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 1999 | 93 | 0.080 |
Why?
| | Cell Count | 2 | 1991 | 321 | 0.080 |
Why?
| | Epitopes | 3 | 1997 | 475 | 0.080 |
Why?
| | Sebaceous Glands | 1 | 2010 | 5 | 0.080 |
Why?
| | Keratolytic Agents | 1 | 2010 | 5 | 0.080 |
Why?
| | Integrins | 1 | 2011 | 90 | 0.080 |
Why?
| | Introns | 4 | 2004 | 260 | 0.080 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 29 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 1993 | 615 | 0.080 |
Why?
| | Decidua | 1 | 2010 | 22 | 0.080 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 93 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 1999 | 196 | 0.080 |
Why?
| | Nevus | 1 | 2010 | 26 | 0.080 |
Why?
| | Carcinogenesis | 3 | 2021 | 230 | 0.080 |
Why?
| | Tumor Microenvironment | 1 | 2015 | 748 | 0.080 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2010 | 2 | 0.080 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2010 | 3 | 0.080 |
Why?
| | Genetic Techniques | 2 | 2005 | 66 | 0.080 |
Why?
| | Caspase 7 | 1 | 2010 | 22 | 0.080 |
Why?
| | Biomarkers, Tumor | 7 | 2009 | 1339 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 2 | 2007 | 120 | 0.080 |
Why?
| | Aneuploidy | 2 | 2007 | 91 | 0.080 |
Why?
| | Genotype | 4 | 2015 | 1875 | 0.080 |
Why?
| | Osteoblasts | 1 | 2011 | 146 | 0.080 |
Why?
| | Organ Specificity | 4 | 2007 | 310 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 17 | 0.080 |
Why?
| | Liver Regeneration | 1 | 2010 | 46 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2012 | 889 | 0.080 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1990 | 62 | 0.080 |
Why?
| | Disease Susceptibility | 5 | 2006 | 347 | 0.070 |
Why?
| | Teratoma | 1 | 2010 | 124 | 0.070 |
Why?
| | Oviducts | 9 | 1982 | 11 | 0.070 |
Why?
| | Neoplasms | 2 | 2006 | 2946 | 0.070 |
Why?
| | Uterus | 1 | 2010 | 228 | 0.070 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1794 | 0.070 |
Why?
| | Down-Regulation | 4 | 2009 | 618 | 0.070 |
Why?
| | Collagen | 2 | 1988 | 460 | 0.070 |
Why?
| | Non-Fibrillar Collagens | 1 | 1988 | 3 | 0.070 |
Why?
| | Pemphigoid, Bullous | 1 | 1988 | 7 | 0.070 |
Why?
| | Muscle, Smooth | 1 | 1990 | 153 | 0.070 |
Why?
| | Osteogenesis | 1 | 2011 | 205 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 616 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2011 | 270 | 0.070 |
Why?
| | Receptor, Notch1 | 2 | 2006 | 63 | 0.070 |
Why?
| | Spindle Apparatus | 1 | 2009 | 95 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 1000 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 1166 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 334 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 445 | 0.070 |
Why?
| | beta-Galactosidase | 2 | 1999 | 76 | 0.070 |
Why?
| | Foot | 1 | 2009 | 109 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 106 | 0.070 |
Why?
| | Hand | 1 | 2009 | 157 | 0.070 |
Why?
| | Genes, Lethal | 2 | 2008 | 31 | 0.070 |
Why?
| | Olfactory Mucosa | 1 | 2008 | 40 | 0.070 |
Why?
| | Cytoplasmic Granules | 4 | 2002 | 60 | 0.070 |
Why?
| | Integrin beta1 | 2 | 2013 | 33 | 0.070 |
Why?
| | Hoof and Claw | 1 | 2007 | 9 | 0.070 |
Why?
| | Cell Death | 1 | 2009 | 383 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 855 | 0.070 |
Why?
| | Bone Marrow | 2 | 2015 | 310 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 459 | 0.060 |
Why?
| | Protein Conformation | 6 | 1992 | 943 | 0.060 |
Why?
| | Langerhans Cells | 2 | 1997 | 12 | 0.060 |
Why?
| | Growth Substances | 2 | 1999 | 138 | 0.060 |
Why?
| | Caspase 9 | 1 | 2007 | 55 | 0.060 |
Why?
| | Species Specificity | 3 | 2000 | 547 | 0.060 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 161 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2006 | 445 | 0.060 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1999 | 35 | 0.060 |
Why?
| | Cell Line, Tumor | 5 | 2015 | 3565 | 0.060 |
Why?
| | Coculture Techniques | 2 | 2024 | 247 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 19 | 0.060 |
Why?
| | Cell Adhesion | 3 | 2015 | 451 | 0.060 |
Why?
| | Adult | 10 | 2020 | 41405 | 0.060 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 63 | 0.060 |
Why?
| | Interleukin-1alpha | 2 | 2020 | 57 | 0.060 |
Why?
| | Ganciclovir | 2 | 1998 | 53 | 0.060 |
Why?
| | Twist-Related Protein 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Biological Assay | 1 | 2007 | 134 | 0.060 |
Why?
| | Mice, SCID | 3 | 2013 | 369 | 0.060 |
Why?
| | Blotting, Northern | 6 | 1992 | 203 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 186 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 338 | 0.060 |
Why?
| | Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| | Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| | Models, Genetic | 3 | 2008 | 536 | 0.060 |
Why?
| | Stomach | 2 | 2006 | 111 | 0.060 |
Why?
| | Autoantigens | 1 | 1988 | 429 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 2001 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 762 | 0.060 |
Why?
| | Antibodies | 2 | 1985 | 398 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 1999 | 372 | 0.060 |
Why?
| | Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2007 | 1172 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1371 | 0.060 |
Why?
| | Cyclins | 2 | 1996 | 79 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1368 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 182 | 0.050 |
Why?
| | Skin Abnormalities | 2 | 2002 | 12 | 0.050 |
Why?
| | Retinal Dehydrogenase | 2 | 2016 | 29 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 1988 | 597 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2006 | 633 | 0.050 |
Why?
| | Embryonic Development | 1 | 2005 | 125 | 0.050 |
Why?
| | Melanins | 1 | 2024 | 16 | 0.050 |
Why?
| | RNA Interference | 3 | 2013 | 477 | 0.050 |
Why?
| | Calcineurin | 1 | 2005 | 106 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 443 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 332 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2024 | 84 | 0.050 |
Why?
| | Boron Compounds | 1 | 2024 | 29 | 0.050 |
Why?
| | Homeodomain Proteins | 2 | 2006 | 525 | 0.050 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 15 | 0.050 |
Why?
| | Transglutaminases | 3 | 1995 | 159 | 0.050 |
Why?
| | Blotting, Southern | 3 | 2001 | 85 | 0.050 |
Why?
| | In Vitro Techniques | 4 | 2013 | 1049 | 0.050 |
Why?
| | Aminopyridines | 1 | 2024 | 129 | 0.050 |
Why?
| | Body Weight | 2 | 2011 | 976 | 0.050 |
Why?
| | United States | 1 | 2021 | 16313 | 0.050 |
Why?
| | Benzamides | 1 | 2024 | 227 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2005 | 373 | 0.050 |
Why?
| | Pregnancy | 5 | 2010 | 7274 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2002 | 335 | 0.050 |
Why?
| | Gene Editing | 1 | 2024 | 90 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 307 | 0.050 |
Why?
| | Vimentin | 4 | 1994 | 54 | 0.050 |
Why?
| | Molecular Structure | 2 | 1994 | 488 | 0.050 |
Why?
| | Time Factors | 5 | 2004 | 7173 | 0.050 |
Why?
| | Vitamin K 3 | 1 | 2002 | 3 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2024 | 166 | 0.050 |
Why?
| | Biomarkers | 5 | 2004 | 4351 | 0.050 |
Why?
| | Genetic Variation | 2 | 1998 | 995 | 0.050 |
Why?
| | S100 Proteins | 2 | 2000 | 35 | 0.050 |
Why?
| | Dacarbazine | 2 | 2012 | 101 | 0.040 |
Why?
| | Keratin-15 | 1 | 2002 | 16 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 293 | 0.040 |
Why?
| | Bioreactors | 1 | 2002 | 50 | 0.040 |
Why?
| | Keratin-5 | 1 | 2002 | 44 | 0.040 |
Why?
| | Immunoenzyme Techniques | 4 | 1993 | 200 | 0.040 |
Why?
| | Isomerism | 1 | 2001 | 56 | 0.040 |
Why?
| | Mesocricetus | 5 | 1993 | 52 | 0.040 |
Why?
| | 3T3 Cells | 3 | 2013 | 157 | 0.040 |
Why?
| | Vitamin A Deficiency | 3 | 1993 | 26 | 0.040 |
Why?
| | Starvation | 1 | 2001 | 23 | 0.040 |
Why?
| | Luteolytic Agents | 1 | 2001 | 1 | 0.040 |
Why?
| | Lasers | 1 | 2002 | 128 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2004 | 432 | 0.040 |
Why?
| | Bone and Bones | 1 | 2004 | 322 | 0.040 |
Why?
| | Mouth Diseases | 1 | 2001 | 48 | 0.040 |
Why?
| | Administration, Topical | 3 | 1997 | 156 | 0.040 |
Why?
| | Autoantibodies | 1 | 1988 | 1513 | 0.040 |
Why?
| | Response Elements | 2 | 2012 | 86 | 0.040 |
Why?
| | Benzo(a)pyrene | 1 | 2000 | 9 | 0.040 |
Why?
| | Nuclear Localization Signals | 1 | 2000 | 16 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2000 | 32 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 37 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 387 | 0.040 |
Why?
| | Dermatitis, Exfoliative | 1 | 2020 | 3 | 0.040 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2000 | 52 | 0.040 |
Why?
| | Cell Survival | 3 | 2013 | 1111 | 0.040 |
Why?
| | Adaptation, Biological | 1 | 2000 | 49 | 0.040 |
Why?
| | Rats | 5 | 1994 | 5613 | 0.040 |
Why?
| | Immunoblotting | 4 | 2003 | 296 | 0.040 |
Why?
| | Chickens | 9 | 1995 | 179 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 55 | 0.040 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 56 | 0.040 |
Why?
| | Repressor Proteins | 2 | 2013 | 429 | 0.040 |
Why?
| | Cell Nucleus | 7 | 2004 | 589 | 0.040 |
Why?
| | Zebrafish | 1 | 2004 | 536 | 0.040 |
Why?
| | Estrenes | 1 | 1999 | 13 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2003 | 273 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 163 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1511 | 0.040 |
Why?
| | Restriction Mapping | 1 | 1999 | 81 | 0.040 |
Why?
| | Genomic Library | 1 | 1999 | 16 | 0.040 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 32 | 0.040 |
Why?
| | Phototherapy | 1 | 2019 | 50 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 52 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 44 | 0.040 |
Why?
| | Protein Transport | 1 | 2000 | 442 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 34 | 0.040 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 1978 | 6 | 0.040 |
Why?
| | Reference Values | 3 | 2002 | 800 | 0.040 |
Why?
| | Dimerization | 1 | 1999 | 189 | 0.040 |
Why?
| | DNA Damage | 2 | 2012 | 440 | 0.040 |
Why?
| | Thrombospondin 1 | 1 | 1998 | 28 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 78 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 143 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 62 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 751 | 0.030 |
Why?
| | Lymphokines | 1 | 1998 | 128 | 0.030 |
Why?
| | Body Patterning | 1 | 1999 | 138 | 0.030 |
Why?
| | Peptides | 1 | 1984 | 1003 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1998 | 69 | 0.030 |
Why?
| | Antigens, Neoplasm | 2 | 1997 | 273 | 0.030 |
Why?
| | Genes, bcl-2 | 1 | 1998 | 22 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2011 | 2420 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 1999 | 197 | 0.030 |
Why?
| | Gamma Rays | 1 | 1998 | 57 | 0.030 |
Why?
| | Age of Onset | 1 | 1999 | 568 | 0.030 |
Why?
| | Psoriasis | 2 | 1996 | 115 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2002 | 1147 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 1997 | 16 | 0.030 |
Why?
| | Thymus Gland | 1 | 1998 | 313 | 0.030 |
Why?
| | Epidermal Growth Factor | 3 | 1993 | 162 | 0.030 |
Why?
| | Retinoid X Receptors | 1 | 1997 | 42 | 0.030 |
Why?
| | Protein Binding | 3 | 2009 | 2249 | 0.030 |
Why?
| | Oxazines | 1 | 1997 | 37 | 0.030 |
Why?
| | Mitotic Index | 1 | 1997 | 25 | 0.030 |
Why?
| | Metaplasia | 3 | 1993 | 57 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2458 | 0.030 |
Why?
| | Receptors, Calcitriol | 1 | 1997 | 56 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2000 | 873 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1998 | 440 | 0.030 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 1997 | 75 | 0.030 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 1997 | 50 | 0.030 |
Why?
| | Luciferases | 2 | 2009 | 155 | 0.030 |
Why?
| | Hybrid Cells | 2 | 1994 | 49 | 0.030 |
Why?
| | Carcinogenicity Tests | 2 | 1994 | 13 | 0.030 |
Why?
| | Hypertrophy | 1 | 1997 | 128 | 0.030 |
Why?
| | Organ Culture Techniques | 4 | 1990 | 154 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1987 | 118 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2016 | 105 | 0.030 |
Why?
| | Body Temperature | 1 | 1997 | 229 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 1993 | 269 | 0.030 |
Why?
| | Extremities | 1 | 1997 | 144 | 0.030 |
Why?
| | Rabbits | 2 | 1996 | 654 | 0.030 |
Why?
| | Kinetics | 5 | 1994 | 1569 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 552 | 0.030 |
Why?
| | Phospholipids | 1 | 1997 | 214 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 82 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 156 | 0.030 |
Why?
| | Biopsy | 2 | 1997 | 1093 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 695 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 217 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 342 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 43 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1995 | 158 | 0.030 |
Why?
| | Interleukins | 1 | 1997 | 248 | 0.030 |
Why?
| | Inhibins | 1 | 1995 | 41 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 65 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 366 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 337 | 0.030 |
Why?
| | Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| | Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| | Benzoates | 1 | 1995 | 51 | 0.030 |
Why?
| | Tetrahydronaphthalenes | 1 | 1995 | 34 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 74 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 1998 | 1281 | 0.030 |
Why?
| | DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 164 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1995 | 362 | 0.030 |
Why?
| | Staining and Labeling | 2 | 2010 | 153 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 1995 | 103 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 1994 | 13 | 0.030 |
Why?
| | Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 840 | 0.030 |
Why?
| | Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1994 | 130 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 20 | 0.030 |
Why?
| | Simian virus 40 | 1 | 1993 | 24 | 0.030 |
Why?
| | Collagen Type IV | 1 | 2014 | 27 | 0.030 |
Why?
| | Chorionic Villi | 1 | 1994 | 25 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 779 | 0.020 |
Why?
| | Laminin | 1 | 1994 | 73 | 0.020 |
Why?
| | alpha Catenin | 1 | 2013 | 11 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2679 | 0.020 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 1993 | 5 | 0.020 |
Why?
| | Multigene Family | 1 | 1994 | 210 | 0.020 |
Why?
| | Clone Cells | 2 | 2010 | 263 | 0.020 |
Why?
| | Cholecalciferol | 1 | 1994 | 61 | 0.020 |
Why?
| | Cell Dedifferentiation | 1 | 2013 | 32 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 46 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 252 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 57 | 0.020 |
Why?
| | Ovariectomy | 1 | 1994 | 166 | 0.020 |
Why?
| | Middle Aged | 5 | 2020 | 36821 | 0.020 |
Why?
| | Sulfur Radioisotopes | 2 | 1990 | 13 | 0.020 |
Why?
| | Antigens, CD | 1 | 2016 | 562 | 0.020 |
Why?
| | DNA Probes | 2 | 1992 | 59 | 0.020 |
Why?
| | Diseases in Twins | 1 | 1994 | 116 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 456 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2016 | 638 | 0.020 |
Why?
| | Collagen Type I | 1 | 2014 | 145 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2013 | 192 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2009 | 6543 | 0.020 |
Why?
| | Protein Biosynthesis | 6 | 1991 | 452 | 0.020 |
Why?
| | Glycoproteins | 1 | 1995 | 358 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2020 | 11947 | 0.020 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 29 | 0.020 |
Why?
| | Lentivirus | 1 | 2013 | 62 | 0.020 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2012 | 28 | 0.020 |
Why?
| | Forecasting | 1 | 1994 | 391 | 0.020 |
Why?
| | Breast | 1 | 1993 | 157 | 0.020 |
Why?
| | Egg Proteins | 3 | 1982 | 20 | 0.020 |
Why?
| | Child | 3 | 2020 | 22979 | 0.020 |
Why?
| | Serine | 1 | 1993 | 143 | 0.020 |
Why?
| | Viruses | 1 | 1994 | 166 | 0.020 |
Why?
| | Bacteriophage lambda | 1 | 1993 | 90 | 0.020 |
Why?
| | Limb Buds | 2 | 2004 | 23 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 90 | 0.020 |
Why?
| | Cysteine | 1 | 1993 | 211 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 296 | 0.020 |
Why?
| | Tritium | 3 | 1994 | 67 | 0.020 |
Why?
| | Myoepithelioma | 1 | 1991 | 3 | 0.020 |
Why?
| | Mutagenicity Tests | 1 | 2011 | 18 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 61 | 0.020 |
Why?
| | Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| | Age Factors | 2 | 1996 | 3372 | 0.020 |
Why?
| | Biological Evolution | 2 | 1985 | 473 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 6 | 0.020 |
Why?
| | Progesterone | 2 | 2010 | 215 | 0.020 |
Why?
| | Rodent Diseases | 1 | 1991 | 28 | 0.020 |
Why?
| | Ovomucin | 2 | 1982 | 9 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2011 | 54 | 0.020 |
Why?
| | Moloney murine leukemia virus | 1 | 1991 | 13 | 0.020 |
Why?
| | Hyperpigmentation | 1 | 2011 | 27 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 269 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 38 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 261 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2017 | 0.020 |
Why?
| | Wnt4 Protein | 1 | 2010 | 20 | 0.020 |
Why?
| | Proteome | 1 | 2015 | 520 | 0.020 |
Why?
| | Immunosorbent Techniques | 2 | 1987 | 18 | 0.020 |
Why?
| | Growth Disorders | 1 | 2011 | 89 | 0.020 |
Why?
| | Embryo Implantation | 1 | 2010 | 34 | 0.020 |
Why?
| | Cytokines | 2 | 2015 | 2086 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 616 | 0.020 |
Why?
| | Swine | 1 | 1993 | 828 | 0.020 |
Why?
| | Infant | 2 | 2009 | 10194 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1997 | 932 | 0.020 |
Why?
| | Pigmentation | 1 | 2010 | 52 | 0.020 |
Why?
| | Mitosis | 1 | 2011 | 194 | 0.020 |
Why?
| | Estrogens | 4 | 1982 | 368 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1993 | 261 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 2010 | 79 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 1990 | 85 | 0.020 |
Why?
| | Adenoma, Pleomorphic | 1 | 1990 | 9 | 0.020 |
Why?
| | Animals, Wild | 1 | 1990 | 65 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1998 | 2017 | 0.020 |
Why?
| | Parotid Neoplasms | 1 | 1990 | 15 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1994 | 1518 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 42 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 88 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2010 | 102 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1912 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 1990 | 254 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1059 | 0.020 |
Why?
| | DNA Repair | 1 | 2012 | 256 | 0.020 |
Why?
| | Liver | 2 | 2002 | 1916 | 0.020 |
Why?
| | Child, Preschool | 2 | 2009 | 12016 | 0.020 |
Why?
| | Anemia | 1 | 2011 | 192 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 139 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2009 | 85 | 0.020 |
Why?
| | Amino Acids | 4 | 2002 | 519 | 0.020 |
Why?
| | Imidazoles | 1 | 2010 | 247 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 180 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1999 | 5476 | 0.020 |
Why?
| | Diethylstilbestrol | 2 | 1979 | 6 | 0.020 |
Why?
| | Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 199 | 0.020 |
Why?
| | Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| | Methionine | 1 | 1989 | 161 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3660 | 0.020 |
Why?
| | Lactation | 1 | 1990 | 195 | 0.020 |
Why?
| | Cell Communication | 1 | 2010 | 329 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 221 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 1988 | 43 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2010 | 229 | 0.020 |
Why?
| | Vitamin A | 2 | 1986 | 62 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 375 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 512 | 0.020 |
Why?
| | Isoelectric Point | 1 | 1987 | 22 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 1988 | 76 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 849 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1386 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1988 | 104 | 0.020 |
Why?
| | Interferon-gamma | 1 | 1990 | 786 | 0.020 |
Why?
| | Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1987 | 43 | 0.020 |
Why?
| | Antigens, Ly | 1 | 1987 | 46 | 0.020 |
Why?
| | Occludin | 1 | 2006 | 12 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2006 | 21 | 0.020 |
Why?
| | Claudin-1 | 1 | 2006 | 17 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2008 | 99 | 0.020 |
Why?
| | Organoids | 1 | 1988 | 146 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1990 | 784 | 0.010 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.010 |
Why?
| | Immunoassay | 1 | 1987 | 109 | 0.010 |
Why?
| | Receptors, Steroid | 1 | 2006 | 42 | 0.010 |
Why?
| | Chemistry | 1 | 1985 | 41 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1985 | 77 | 0.010 |
Why?
| | Fluocinolone Acetonide | 1 | 1985 | 15 | 0.010 |
Why?
| | X-Ray Diffraction | 1 | 1985 | 84 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1721 | 0.010 |
Why?
| | Cattle | 2 | 1988 | 948 | 0.010 |
Why?
| | HeLa Cells | 1 | 2007 | 633 | 0.010 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1985 | 196 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1986 | 222 | 0.010 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 18 | 0.010 |
Why?
| | Calcineurin Inhibitors | 1 | 2005 | 69 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2223 | 0.010 |
Why?
| | YY1 Transcription Factor | 1 | 2004 | 25 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 95 | 0.010 |
Why?
| | Base Composition | 1 | 1984 | 82 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1987 | 480 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2004 | 33 | 0.010 |
Why?
| | Thymidine | 2 | 1994 | 60 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 70 | 0.010 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1988 | 961 | 0.010 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2004 | 71 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2004 | 93 | 0.010 |
Why?
| | Aged | 3 | 2020 | 26514 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2003 | 20 | 0.010 |
Why?
| | Craniofacial Abnormalities | 1 | 2004 | 78 | 0.010 |
Why?
| | Weaning | 1 | 2003 | 51 | 0.010 |
Why?
| | Esophageal Diseases | 1 | 2003 | 30 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 1990 | 1514 | 0.010 |
Why?
| | Mice, Hairless | 2 | 1994 | 47 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14437 | 0.010 |
Why?
| | Terminology as Topic | 1 | 1985 | 261 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 1987 | 566 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2003 | 83 | 0.010 |
Why?
| | Adolescent | 2 | 2020 | 22825 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1072 | 0.010 |
Why?
| | Fibroblast Growth Factors | 1 | 2004 | 188 | 0.010 |
Why?
| | Cheek | 2 | 1993 | 16 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1992 | 0.010 |
Why?
| | Fertility | 1 | 2002 | 175 | 0.010 |
Why?
| | RNA, Small Nuclear | 1 | 1981 | 40 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 48 | 0.010 |
Why?
| | Biotransformation | 1 | 2000 | 62 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1984 | 698 | 0.010 |
Why?
| | Sequence Homology | 1 | 1999 | 43 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2030 | 0.010 |
Why?
| | Risk Factors | 1 | 1994 | 11017 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1999 | 22 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1672 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1978 | 25 | 0.010 |
Why?
| | Globins | 1 | 1978 | 21 | 0.010 |
Why?
| | Reticulocytes | 1 | 1978 | 17 | 0.010 |
Why?
| | Polyribosomes | 1 | 1978 | 22 | 0.010 |
Why?
| | Cholera Toxin | 2 | 1988 | 29 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 103 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1989 | 180 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 1998 | 43 | 0.010 |
Why?
| | Drug Stability | 1 | 1978 | 169 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1978 | 82 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 1981 | 350 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 334 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1986 | 38 | 0.010 |
Why?
| | Desmogleins | 1 | 1996 | 3 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 421 | 0.010 |
Why?
| | Desmoplakins | 1 | 1996 | 25 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 1979 | 406 | 0.010 |
Why?
| | Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| | Vibrissae | 1 | 1995 | 11 | 0.010 |
Why?
| | Activins | 1 | 1995 | 29 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1995 | 14 | 0.010 |
Why?
| | Xenopus | 1 | 1995 | 87 | 0.010 |
Why?
| | Palate | 1 | 1995 | 40 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 679 | 0.010 |
Why?
| | Musculoskeletal System | 1 | 1995 | 54 | 0.010 |
Why?
| | Estrus | 1 | 1994 | 16 | 0.010 |
Why?
| | Acetone | 1 | 1994 | 12 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 1997 | 499 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1997 | 514 | 0.010 |
Why?
| | Skull | 1 | 1995 | 164 | 0.010 |
Why?
| | Cell Fusion | 1 | 1993 | 48 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 251 | 0.010 |
Why?
| | Dendritic Cells | 1 | 1997 | 510 | 0.010 |
Why?
| | Organelles | 1 | 1991 | 53 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1991 | 138 | 0.010 |
Why?
| | Retroviridae | 1 | 1991 | 100 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1990 | 62 | 0.000 |
Why?
| | Trypsin | 1 | 1990 | 75 | 0.000 |
Why?
| | von Willebrand Factor | 1 | 1990 | 85 | 0.000 |
Why?
| | DNA, Recombinant | 2 | 1979 | 48 | 0.000 |
Why?
| | RNA Probes | 1 | 1988 | 12 | 0.000 |
Why?
| | Autoradiography | 1 | 1988 | 66 | 0.000 |
Why?
| | HLA-DR Antigens | 1 | 1990 | 220 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 79 | 0.000 |
Why?
| | Metaphase | 1 | 1988 | 34 | 0.000 |
Why?
| | Cytoplasm | 1 | 1988 | 255 | 0.000 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 1988 | 49 | 0.000 |
Why?
| | Microbial Collagenase | 1 | 1987 | 8 | 0.000 |
Why?
| | Culture Techniques | 1 | 1987 | 66 | 0.000 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 110 | 0.000 |
Why?
| | Cross Reactions | 1 | 1988 | 130 | 0.000 |
Why?
| | Light | 1 | 1990 | 403 | 0.000 |
Why?
| | Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1987 | 39 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1987 | 27 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 118 | 0.000 |
Why?
| | Diterpenes | 1 | 1986 | 26 | 0.000 |
Why?
| | Genetic Markers | 1 | 1987 | 338 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2920 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1988 | 863 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2954 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 8430 | 0.000 |
Why?
| | Poly A | 1 | 1982 | 50 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1979 | 62 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 17560 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|